News Formal

Canopy Growth signs deal to sell its C3 Cannabinoid Compound Company GmbH subsidiary

  • 📰 globeandmail
  • ⏱ Reading Time:
  • 17 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 10%
  • Publisher: 92%

इंडिया समाचार समाचार

इंडिया ताज़ा खबर,इंडिया मुख्य बातें

Under the agreement, Canopy will receive an upfront payment of $115.5-million. The deal, which requires regulatory approvals, is expected to close by Jan. 31, 2022

says it has signed a deal to sell its C3 Cannabinoid Compound Company GmbH subsidiary to German company Dermapharm Holding SE.It will also receive up an additional $61.4-million, subject to the achievement of certain milestones by the business.

The business being sold develops and manufactures pharmaceutical products and includes Spectrum Therapeutics GmbH, THC Pharm GmbH The Health Concept and Spectrum Therapeutics Austria GmbH.Your time is valuable. Have the Top Business Headlines newsletter conveniently delivered to your inbox in the morning or evening.

 

आपकी टिप्पणी के लिए धन्यवाद। आपकी टिप्पणी समीक्षा के बाद प्रकाशित की जाएगी।
हमने इस समाचार को संक्षेप में प्रस्तुत किया है ताकि आप इसे तुरंत पढ़ सकें। यदि आप समाचार में रुचि रखते हैं, तो आप पूरा पाठ यहां पढ़ सकते हैं। और पढो:

 /  🏆 5. in İN

इंडिया ताज़ा खबर, इंडिया मुख्य बातें